AlphaNa Bioscience Initiates Phase IIb Clinical Trial of AFN0328, a Therapeutic mRNA Vaccine for HPV-Associated Disease

AlphaNa Bioscience Publishes in Science: New Insights into Systemic Regulation of Drug Delivery

AlphaNa Bioscience Publishes Data-Driven Platform for Organ-Selective mRNA Delivery in the Journal of the American Chemical Society

AlphaNa Bioscience Leads Key Research in National Major Science and Technology Project on Infectious

AlphaNa Bioscience Advances Programmable Immune Technologies Through National Infectious Disease Research Initiative